BNF for Children (BNFC) 2018-2019 [PDF]

BNF for Children (BNFC) 2018-2019

The BNF for Children (BNFC) 2018-2019 provides essential practical information to all healthcare professionals involved in the prescribing, dispensing, monitoring and administration of medicines to children. It addresses a significant knowledge gap in many areas of paediatric practice by providing practical information on the use of medicines in children of all ages from birth to adolescence. 

Recommendations in the BNFC have been constructed on the basis of authoritative sources, emerging evidence and best practice guidelines. The content has been carefully validated by a network of paediatric experts and the process is overseen by a paediatric formulary committee.  The BNF for Children 2018-2019 has been revised and revalidated to reflect changes in product availability, emerging safety concerns and shifts in clinical practice.

Product details

• Series: BNF for Children
• Paperback: 1120 pages
• Publisher: Pharmaceutical Press; 1 edition (September 21, 2018)
• Language: English
• ISBN-10: 0857113364
• ISBN-13: 978-0857113368

download link:

mediafire

BNF 76 September 2018 76th Revised Edition 2019 [PDF]

BNF 76 September 2018 76th Revised Edition 2019

Compiled with the advice of clinical experts and continually updated to reflect the latest evidence from credible sources worldwide, the new edition of the British National Formulary 76 (BNF) provides up-to-date guidance on prescribing, dispensing, and administering medicines.

Access to the latest edition of the BNF is vital for healthcare professionals, as it reflects current best practice as well as legal and professional guidelines relating to the uses of medicines.

NICE has accredited the editorial process used by the British National Formulary to produce its resources.

Compiled with the advice of clinical experts and continually updated to reflect the latest evidence from credible sources worldwide, this essential reference provides up-to-date guidance on prescribing, dispensing, and administering medicines.

Not only does the BNF include a widely accepted framework for the drug management of common diseases, it also includes details of medicines prescribed in the UK, with special reference to their uses, cautions, contraindications, side-effects and dosage.

This allows treatment to be tailored to the individual needs of each patient. 

The BNF is updated in print every six months by an expert team of pharmacists; validated by a network of leading clinicians from many spheres of clinical practice; and published under the authority of a Joint Formulary Committee. The BNF reflects current best

practice as well as legal and professional guidelines relating to the use of medicines. As a result it is used widely as a touchstone reference, and cited by regulatory bodies and courts as a source of authority.

Product details

• Series: British National Formulary
• Paperback: 1640 pages
• Publisher: Pharmaceutical Press; 76th Revised edition edition (September 21, 2018)
• Language: English
• ISBN-10: 0857113380
• ISBN-13: 978-0857113382

Download link

mediafire

Sanford Guide Antimicrobial Rx v2.1.10 [android version]

Requirements: Android OS 4.1 +
Overview: For 45 years, The Sanford Guide to Antimicrobial Therapy has been the leading clinical reference for treatment of infectious diseases.

The Sanford Guide to Antimicrobial Therapy ($29.99/yr in-App subscription) provides clinicians with infectious disease information that is current, concise, and reliable. Full text search provides fast access, detailed search results, and highlighted search terms. Intuitive menus provide another way to navigate our extensive content collection. Together with bookmarks and notes, you can organize content according to the way you work. Your subscription includes monthly content updates.

Since 1969, The Sanford Guide to Antimicrobial Therapy has been the leading clinical reference for treatment of infectious diseases. Coverage includes: clinical syndromes (organized by anatomic system/site of infection), pathogens (bacterial, fungal, mycobacterial, parasitic and viral), anti-infective agents (dosing, adverse effects, activity, pharmacology, interactions), specialized dosing tables and tools, calculators and preventative therapy, all evidence-based and extensively referenced.

What's New
You can now search by drug trade names!

This app has NO advertisements

Download
Mediafire

DRUG DOSES FRANK SHANN 2017 PDF

The booklet includes the dose of every drug commonly prescribed for systemic use in both adults and children, except for diagnostic agents. The booklet does not list the side effects of drugs, indications for their use, or modifications for renal or hepatic failure.


DOWNLOAD LINK:
MEDIAFIRE

BNF children 2017-2018 pdf

The BNF for Children (BNFC) 2017-2018 provides essential practical information to all healthcare professionals involved in the prescribing, dispensing, monitoring and administration of medicines to children. It has been revised and revalidated to reflect changes in product availability, emerging safety concerns and shifts in clinical practice. The resource addresses a significant knowledge gap in many areas of paediatric practice by providing practical information on the use of medicines in children of all ages from birth to adolescence.

download link:
mediafire

BNF 74 pdf version

British National Formulary (BNF 74)

BNF 74 has been compiled with the advice of clinical experts and continually updated to reflect the latest evidence from credible sources worldwide. It provides up-to-date guidance on prescribing, dispensing, and administering medicines. Access to the latest edition of the BNF is vital for healthcare professionals, as it reflects current best practice as well as legal and professional guidelines relating to the uses of medicines.

Contents

Content of the BNF reflects current best practice as well as legal and professional guidelines relating to the uses of medicines. The resource includes:

• Guidance on the drug management of common conditions
• Details of medicines prescribed within the UK with special reference to their uses, cautions, contra-indications, side-effects, doses and relative costs. This allows treatment to be tailored to the individual needs of each patient.
• Guidance on prescribing, monitoring, dispensing and adminstering medicines.

The content is updated every 6 months in print, making it an up-to-date source of prescribing advice for informed decision-making.

download link:

mediafire

BNF 73 march 2017 pdf

BNF 73 (March 2017) is the authoritative guide to prescribing, dispensing and administering medicines for all healthcare professionals.  Access to the latest edition of BNF is vital for healthcare professionals.

Compiled with the advice of clinical experts and continually updated to reflect the latest evidence from credible sources worldwide, this essential reference provides up-to-date guidance on prescribing, dispensing, and administering medicines.

Not only does the BNF include a widely accepted framework for the drug management of common diseases, it also includes details of medicines prescribed in the UK, with special reference to their uses, cautions, contraindications, side-effects and dosage. This allows treatment to be tailored to the individual needs of each patient.

The BNF is updated in print every six months by an expert team of pharmacists; validated by a network of leading clinicians from many spheres of clinical practice; and published under the authority of a Joint Formulary Committee. The BNF reflects current best practice as well as legal and professional guidelines relating to the use of medicines. As a result it is used widely as a touchstone reference, and cited by regulatory bodies and courts as a source of authority.

New content and updates:
 Updated guidance for conditions including anal fissure, coeliac disease, dementia, exocrine pancreatic insufficiency, food allergy, multiple sclerosis and short bowel syndrome. New prescribing guidance for biological and biosimilar medicines.
 New drug monographs alirocumab, blinatumomab, brivaracetam, ceftobiprole, clevidipine, elvitegravir, isavuconazole, nivolumab and panobinostat.
 New safety information about fire risk with paraffin-based skin emollients on dressings and clothing and advice on minimising the risk of infections when being treated with idelalisib.
 Updated guidance on starting routine for oral progestogen-only contraceptives and the use of sodium glucose co-transporter 2 inhibitors as monotherapy for treating type 2 diabetes.

Download link:

mediafire